-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Context Therapeutics Inc. quarterly/annual Operating Income (Loss) history and change rate from Q3 2020 to Q3 2025.
- Context Therapeutics Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$10.6M, a 43.3% increase year-over-year.
- Context Therapeutics Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$30.2M, a 7.18% increase year-over-year.
- Context Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$29.9M, a 19.3% decline from 2023.
- Context Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$25.1M, a 63% decline from 2022.
- Context Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$15.4M, a 46.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)